MC-2024
TEST REPORT Sample Coll. By : non USLL
Reg. No. : 50700114515 Reg. Date : 13-Jul-2025 16:43 Ref.No : Approved On : 14-Jul-2025 17:03
Name : POOJA SINGH Collected On : 13-Jul-2025 16:43
Age : 29 Years Gender: Female Pass. No. : Dispatch At :
Ref. By : Ruchica Goel (OBS/GYN) Tele No. : 9005328980
Location : UNIDX WALKIN @ NORTH ZONE
Test Name Results Units Bio. Ref. Interval
Second trimester test (Quadruple marker) AutoDELFIA®
Method:Time-resolved fluoroimmunoassay
AFP 51.8 U/mL Gestational week
Fluoroimmunometric assay
14 13.6 - 44.1
15 15.7 - 49.5
16 17.6 - 30.6
17 20.2 - 61.0
18 22.1 - 39.3
19 26.4 - 81.2
20 28.9 - 89.9
21 33.4 - 107
uE3 5.76 nmol/L Gestational week
Fluoroimmunometric assay
14 1.02 - 2.74
15 1.58 - 3.91
16 2.08 - 4.50
17 2.44 - 6.26
18 3.37 - 7.44
19 4.00 - 9.48
20 4.73 - 12.4
21 6.02 - 12.5
Beta-HCG 8.21 ng/mL Gestational week
Fluoroimmunometric assay
14 8.9 - 69.9
15 7.2 - 54.8
16 5.9 - 44.9
17 4.9 - 37.8
18 4.1 - 29.8
19 3.4 - 25.8
20 3.2 - 22.0
21 2.6 - 18.3
This is an electronically authenticated report.“Please verify the authenticity of this report by scanning the QR code to ensure data integrity.”
Test done from collected sample.
Approved by: Dr. Parikshit Thakkar
Reg. No.:-G-15477
Page 1 of 4
Generated On : 14-Jul-2025 17:04
MC-2024
TEST REPORT Sample Coll. By : non USLL
Reg. No. : 50700114515 Reg. Date : 13-Jul-2025 16:43 Ref.No : Approved On : 14-Jul-2025 17:03
Name : POOJA SINGH Collected On : 13-Jul-2025 16:43
Age : 29 Years Gender: Female Pass. No. : Dispatch At :
Ref. By : Ruchica Goel (OBS/GYN) Tele No. : 9005328980
Location : UNIDX WALKIN @ NORTH ZONE
Inhibin A 337.3 pg/mL Gestational week
Fluoroimmunometric assay
14 133 - 519
15 134 - 395
16 102 - 444
17 132 - 436
18 123 - 363
19 132 - 399
20 89 - 450
Interpretation Screening test is negative. This means that
the risk (chance) of the fetus having Trisomy
21 (Downs syndrome), Trisomy 18 (Edward
syndrome), Trisomy 13 (Patau syndrome) or
open neural tube defect is low.
Sample Type: Serum
Comments
• Quadruple marker test is a screening test done between 15 to 21weeks +6 days of pregnancy to identify fetus at risk of
having trisomy 21 ( Down's syndrome), trisomy 18 (Edward syndrome), trisomay 13 (Patau syndrome) and open neural
tube defect.
• Calculation of statistical risk has been done by using FMF approved LifeCycle software from PerkinElmer Life and
Analytical Sciences.
• This is a screening test and hence confirmation of positive screen test is recommended.
• 1:250 risk means, out of 250 women having similar history and results, 1 may have abnormality.
• It is advisable to ask for repeat calculations (not the test), in case history provided is not correct.
• All software may not give similar risk factor for the similar data.
------------------ End Of Report ------------------
This is an electronically authenticated report.“Please verify the authenticity of this report by scanning the QR code to ensure data integrity.”
Test done from collected sample.
Approved by: Dr. Parikshit Thakkar
Reg. No.:-G-15477
Page 2 of 4
Generated On : 14-Jul-2025 17:04
PATIENT REPORT SINGH POOJA 14/07/2025
Requestor: -, -
REQUESTOR: DOCTOR: REQUESTOR CODE: REQUESTOR TYPE:
- - - -
REQUESTOR PHONE 1: FACILITY:
- -
Patient 250700114515: SINGH, POOJA
PATIENT ID: LAST NAME: FIRST NAME:
250700114515 SINGH POOJA
BIRTH DATE: ETHNICITY:
15/11/1995 South Asian
Pregnancy, Calculated EDD: 10/12/2025 (MAEDD: 30.07)
MAEDD: CALCULATED EDD: GEST. DATE:
30.07 10/12/2025 05/03/2025
SELECTED GEST. METHOD: SMOKING STATUS: INSULIN DEP. DIABETIC:
BPD Non smoker No
NO. OF FETUSES: MONOZYGOUS: MATERNAL WEIGHT [KG]:
1 No 60
SYSTEMIC LUPUS ERYTHEMATOSUS: ANTI-PHOSPHOLIPID SYNDROME: PAST T21 - DOWN'S SYNDROME:
No No No
PAST T18 - EDWARDS' SYNDROME: PAST T13 - PATAU'S SYNDROME: RISK ASSESSED:
No No At term
SCREENING PROTOCOL:
Screening_4.0
Biochemistry
SAMPLE ID: SPECIMEN COLLECTED: GEST. AT SAMPLE DATE (W + D): WEIGHT [KG]:
250700114515 11/07/2025 18 w 2 d 60
Ultrasound
SCAN DATE: CRL: BPD: GEST. AT SAMPLE DATE (W + D):
10/07/2025 - 40 18 w 1 d
CRL (#2): BPD (#2): GEST. AT MANUAL ENTRY (W + D): SPECIMEN COLLECTED:
- - 0w0d 10/07/2025
Tests
TEST SAMPLE ID DATE GEST. AT SAMPLE VALUE UNIT CORR. MOM WEIGHT [KG]
DATE (W + D)
AFP (Signed) 250700114515 11/07/2025 18 w 2 d 51.8 U/mL 1.25 60
hCGb (Signed) 250700114515 11/07/2025 18 w 2 d 8.21 ng/mL 0.82 60
INHIBIN (Signed) 250700114515 11/07/2025 18 w 2 d 337.3 pg/mL 1.5 60
UE3UPD (Signed) 250700114515 11/07/2025 18 w 2 d 5.76 nmol/L 1.18 60
Risks, Risk assessed: At term
RISK NAME: RISK RESULT: RISK: TWIN RISK RESULT: TWIN RISK: AGE RISK: CUT-OFF:
T21 (Signed) Low 1:10503 - - 1:958 1:250
RISK NAME: RISK RESULT: RISK: TWIN RISK RESULT: TWIN RISK: AGE RISK: CUT-OFF:
T18 (Signed) Low 1:100000 - - 1:8618 1:100
RISK NAME: RISK RESULT: RISK: TWIN RISK RESULT: TWIN RISK: AGE RISK: CUT-OFF:
T13 (Signed) Low 1:70040 - - 1:25878 1:100
RISK NAME: RISK RESULT: RISK: TWIN RISK RESULT: TWIN RISK: AGE RISK: CUT-OFF:
NTD (Signed) Low - - - - 2.5
REPORT CREATED BY: REPORT CREATED AT:
14/07/2025 4:41 PM
UNIPATH
1/2
PATIENT REPORT SINGH POOJA 14/07/2025
PLEASE NOTE:
REPORT CREATED BY: REPORT CREATED AT:
14/07/2025 4:41 PM
UNIPATH
2/2
